A functional polymorphism in XRCC1 gene is associated with lung cancer risk in a Korean population

S. S. Yoo, C. Jin, K. J. Choi, S. Y. Lee, Y. D. Lee, S. Y. Lee, J. Lee, S. I. Cha, C. H. Kim, J. Y. Park (Daegu, Republic Of Korea)

Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Session: Pathology and prognostic factors of thoracic tumours
Session type: Poster Discussion
Number: 514
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Abstract

Defects on DNA repair system are associated with carcinogenesis. It has been reported that a number of XRCC1 polymorphisms are related with lung cancer risk. We investigated the relationship between 5 potentially functional polymorphisms and lung cancer risk in a Korean population. In total, 610 lung cancer patients and 610 healthy controls were enrolled in this case-control study. Among 5 polymorphisms, the rs25489G>A was significantly associated with lung cancer risk (codominant model, odds ratio = 0.65, 95 % confidence interval = 0.49-0.87, P value = 0.003). When stratified according to smoking status, age, gender and tumor histology, the rs25489G>A was associated with lung cancer risk in never smoker, young age, female and adenocarcinoma (P value = 0.004, 0.003. 0.001 and < 0.001, respectively). These findings suggest that the rs25489 of XRCC1 may contribute to genetic susceptibility to lung cancer.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. S. Yoo, C. Jin, K. J. Choi, S. Y. Lee, Y. D. Lee, S. Y. Lee, J. Lee, S. I. Cha, C. H. Kim, J. Y. Park (Daegu, Republic Of Korea). A functional polymorphism in XRCC1 gene is associated with lung cancer risk in a Korean population. Eur Respir J 2014; 44: Suppl. 58, 514

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Polymorphism of HLA-G gene promotor in patients with non small cell lung cancer
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014

The significance of HSP90AA1, HSP90AB1 and HSP90B1 gene polymorphisms in a Turkish population with non-small cell lung cancer
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014

The association of cyclooxygenase 2 single-nucleotide polymorphisms with susceptibility to and severity of non-small cell lung cancer
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015


Relationship between risk factors for lung cancer and tumor size
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014


Association between leptin and risk of lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016


Significance of EGFR expression patterns in patients with non-small cell lung cancer – Evaluation on protein- and/or gene level?
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014


Prognostic value of survivin gene promoter polymorphisms in non-small cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016

LATE-BREAKING ABSTRACT: Glutathione-S-transferase P1 Ile105Val polymorphism associated with elevated lung function and reduced risk of lung cancer and death in 66,000 individuals
Source: International Congress 2014 – Genes and environment in asthma and COPD
Year: 2014

Methilation status in EBUS-NA samples of lung cancer
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014

Investigation of survivin gene expression in non small cell lung cancer
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014

Association of the endothelin-1 and endothelin A receptor genetic polymorphisms and non-small cell lung cancer in Taiwan
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016


Metabolic signatures associated with lung cancer using serum samples. Influence of hemolysis
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014


Metabolomic analysis of serum samples from patients with lung cancer
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014


The value of miR221 and miR222 as a biomarker in non small cell lung cancer
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014

Telomere-associated gene network in lung adenocarcinoma
Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey
Year: 2015



Frequency and type of EGFR mutations in patients with adenocarcinoma of the lung
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013


The effects of polymorphisms identified in genome-wide association studies of never-smoking females on the prognosis of non-small cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016

The prognostic value of KRAS mutation according to the gene's
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014

Functional impairment of NK cells in non-small-cell lung cancer
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014

Weight loss cutoff level as a key variable related to death risk among advanced lung cancer patients
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014